Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.

Sanacora G.

J Clin Psychiatry. 2009 Oct;70(10):1473-5. doi: 10.4088/JCP.09ac05680blu. Review. No abstract available.

PMID:
19906350
2.

Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.

Sanacora G.

J Clin Psychiatry. 2009 Nov;70(11):1604-5. doi: 10.4088/JCP.09ac05757blu. Review. No abstract available.

PMID:
20031105
3.

Glutamate and depression: clinical and preclinical studies.

Paul IA, Skolnick P.

Ann N Y Acad Sci. 2003 Nov;1003:250-72. Review.

PMID:
14684451
4.

An update on the role of glutamate in the pathophysiology of depression.

Mitchell ND, Baker GB.

Acta Psychiatr Scand. 2010 Sep;122(3):192-210. doi: 10.1111/j.1600-0447.2009.01529.x. Epub 2010 Jan 25. Review.

PMID:
20105149
5.

On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.

Pałucha A, Pilc A.

Pol J Pharmacol. 2002 Nov-Dec;54(6):581-6. Review.

6.

The role of glutamate on the action of antidepressants.

Hashimoto K.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1558-68. doi: 10.1016/j.pnpbp.2010.06.013. Epub 2010 Jun 20. Review.

PMID:
20600468
7.

Synaptic transmission: well-placed modulators.

Forsythe ID, Barnes-Davies M.

Curr Biol. 1997 Jun 1;7(6):R362-5. Review.

8.

Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.

Correll GE, Futter GE.

Pain Med. 2006 Jan-Feb;7(1):92-5. No abstract available.

PMID:
16533209
9.

Metabotropic glutamate receptors in the control of mood disorders.

Witkin JM, Marek GJ, Johnson BG, Schoepp DD.

CNS Neurol Disord Drug Targets. 2007 Apr;6(2):87-100. Review.

PMID:
17430147
10.

[Modern aspects of investigation and clinical application of glutamatergic agents].

Petrov VI, Onishchenko NV.

Eksp Klin Farmakol. 2002 Jul-Aug;65(4):66-70. Review. Russian.

PMID:
12449079
11.

Amyloid beta peptides and glutamatergic synaptic dysregulation.

Parameshwaran K, Dhanasekaran M, Suppiramaniam V.

Exp Neurol. 2008 Mar;210(1):7-13. Epub 2007 Oct 24. Review.

PMID:
18053990
12.

Emerging role of glutamate in the pathophysiology of major depressive disorder.

Hashimoto K.

Brain Res Rev. 2009 Oct;61(2):105-23. doi: 10.1016/j.brainresrev.2009.05.005. Epub 2009 May 28. Review.

PMID:
19481572
13.

[The role of cluster receptor state in synaptic plasticity].

Murzina GB.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2008 May-Jun;58(3):276-93. Review. Russian.

PMID:
18689239
14.

Glutamate-based antidepressants: 20 years on.

Skolnick P, Popik P, Trullas R.

Trends Pharmacol Sci. 2009 Nov;30(11):563-9. doi: 10.1016/j.tips.2009.09.002. Review.

PMID:
19837463
15.

The involvement of glutamate in the pathophysiology of depression.

Palucha A, Pilc A.

Drug News Perspect. 2005 May;18(4):262-8. Review.

PMID:
16034483
16.

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Palucha A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1545-53. Review.

PMID:
17107280
17.
18.

Ketamine and other potential glutamate antidepressants.

Dutta A, McKie S, Deakin JFW.

Psychiatry Res. 2015 Jan 30;225(1-2):1-13. doi: 10.1016/j.psychres.2014.10.028. Epub 2014 Nov 13. Review.

PMID:
25467702
19.

Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

Nicoletti F, Bruno V, Copani A, Casabona G, Knöpfel T.

Trends Neurosci. 1996 Jul;19(7):267-71. Review.

PMID:
8799968
20.

Effect of muramyl dipeptides on postsynaptic GABA, NMDA, and AMPA receptors and presynaptic NMDA receptors in rat brain.

Grigoriev VV, Petrova LN, Gabreliyan AV, Ivanova TA.

Bull Exp Biol Med. 2008 Sep;146(3):276-8.

PMID:
19240837

Supplemental Content

Support Center